tiprankstipranks
Trending News
More News >
Biocon Limited (IN:BIOCON)
:BIOCON
India Market

Biocon Limited (BIOCON) Stock Statistics & Valuation Metrics

Compare
2 Followers

Total Valuation

Biocon Limited has a market cap or net worth of ₹409.52B. The enterprise value is ₹413.15B.
Market Cap₹409.52B
Enterprise Value₹413.15B

Share Statistics

Biocon Limited has 1,200,600,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,200,600,000
Owned by Insiders
Owned by Institutions0.07%

Financial Efficiency

Biocon Limited’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 2.02%.
Return on Equity (ROE)0.05
Return on Assets (ROA)0.02
Return on Invested Capital (ROIC)2.02%
Return on Capital Employed (ROCE)0.03
Revenue Per Employee
Profits Per Employee
Employee Count
Asset Turnover0.26
Inventory Turnover1.05

Valuation Ratios

The current PE Ratio of Biocon Limited is 40.08. Biocon Limited’s PEG ratio is -1.86.
PE Ratio40.08
PS Ratio0.00
PB Ratio1.38
Price to Fair Value1.88
Price to FCF195.08
Price to Operating Cash Flow13.29
PEG Ratio-1.86

Income Statement

In the last 12 months, Biocon Limited had revenue of 150.52B and earned 10.13B in profits. Earnings per share was 8.46.
Revenue150.52B
Gross Profit98.55B
Operating Income13.32B
Pretax Income18.87B
Net Income10.13B
EBITDA44.71B
Earnings Per Share (EPS)8.46

Cash Flow

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00

Dividends & Yields

Biocon Limited pays an annual dividend of ₹0.5, resulting in a dividend yield of 0.15%
Dividend Per Share₹0.5
Dividend Yield0.15%
Payout Ratio23.95%
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.45
52-Week Price Change4.74%
50-Day Moving Average332.36
200-Day Moving Average348.10
Relative Strength Index (RSI)65.43
Average Volume (3m)109.97K

Important Dates

Biocon Limited upcoming earnings date is Jul 24, 2025, TBA Not Confirmed.
Last Earnings DateMay 8, 2025
Next Earnings DateJul 24, 2025
Ex-Dividend DateJul 04, 2025

Financial Position

Biocon Limited as a current ratio of 1.14, with Debt / Equity ratio of 100.85%
Current Ratio1.14
Quick Ratio0.79
Debt to Market Cap0.44
Net Debt to EBITDA3.39
Interest Coverage Ratio1.48

Taxes

In the past 12 months, Biocon Limited has paid 4.57B in taxes.
Income Tax4.57B
Effective Tax Rate0.24

Enterprise Valuation

Biocon Limited EV to EBITDA ratio is 12.47, with an EV/FCF ratio of 32.45.
EV to Sales3.70
EV to EBITDA12.47
EV to Free Cash Flow32.45
EV to Operating Cash Flow13.73

Balance Sheet

Biocon Limited has ₹50.23B in cash and marketable securities with ₹183.62B in debt, giving a net cash position of ₹133.39B billion.
Cash & Marketable Securities₹50.23B
Total Debt₹183.62B
Net Cash₹133.39B
Net Cash Per Share₹111.10
Tangible Book Value Per Share₹5.47

Margins

Gross margin is 67.22%, with operating margin of 8.85%, and net profit margin of 6.73%.
Gross Margin67.22%
Operating Margin8.85%
Pretax Margin12.53%
Net Profit Margin6.73%
EBITDA Margin29.70%
EBIT Margin18.50%

Analyst Forecast

The average price target for Biocon Limited is ₹377.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target₹377.50
Price Target Upside8.92% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast
EPS Growth Forecast

Scores

Smart ScoreN/A
AI Score
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis